![](https://www.worldpharmatoday.com/images/nBanners/Docuvera-728x90.jpeg")
Merck KGaA In Deal With HAPPYneuron To Offer E-Health Solution For MS Patients
HAPPYneuron will be available for inclusion in Merck’s MSdialog platform for use with Rebif®...
McKesson Launches NEW Drug Spend Intelligence Tool
McKesson announced the launch of its new Drug Spend Intelligence™ tool. Designed by hospital pharmacists,...
Novartis Access
The menace of noncommunicable diseases (NCDs) like cardiovascular diseases, diabetes and cancer in the developing...
Teva’s unique Talent Management program facilitates early detection of employees with high potential
Leadership Development Our vision is to consistently develop individuals and improve overall performance...
Mene Pangalos elected to the Fellowship of the Academy of Medical Sciences
IMED leader one of 48 new fellows recognised for the advancement of medical science in...
AstraZeneca and the University of Cambridge announce new joint PhD and clinical research scholarships
AstraZeneca and the University of Cambridge today announced three new joint schemes to support more...
Biogen to acquire British biopharmaceutical firm Convergence
US-based Biogen Idec is set to acquire British clinical-stage biopharmaceutical company, Convergence Pharmaceuticals. ...
Ireland’s Shire to acquire NPS Pharmaceuticals for $5.2bn
Irish drugmaker Shire has signed a merger agreement to acquire US-based NPS Pharmaceuticals for $5.2bn....
Insourcing IV Sterile Compounding
Determined to cement access to reliable and safe sources for crucial IV drug admixtures, a...
Novartis buys GSK’s cancer drugs for $16 bn in three-part deal
Global pharma major Novartis will acquire GlaxoSmithKline Plc's (GSK) cancer drugs portfolio for $16 billion...